<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04262934</url>
  </required_header>
  <id_info>
    <org_study_id>VITADIAL</org_study_id>
    <nct_id>NCT04262934</nct_id>
  </id_info>
  <brief_title>Does Correction of 25 OH-VITAmin D With Cholecalciferol Supplementation Increase Muscle Strength in hemoDIALysis Patients?</brief_title>
  <acronym>VITADIAL</acronym>
  <official_title>Multicenter Randomized Study : Does Correction of 25 OH-VITAmin D With Cholecalciferol Supplementation Increase Muscle Strength in hemoDIALysis Patients?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Phoceen de Nephrologie</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut Phoceen de Nephrologie</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Muscle strength decreases as renal failure progresses. Low muscle strength affects more than
      50% of hemodialysis patients and leads to daily life activities impairment. In the general
      population, numerous studies have linked low 25OH-vitamin D (25OHD) concentrations to the
      loss of the muscle strength and low physical performances. Data on native vitamin D and
      muscle function are scarce in the chronic renal failure (CKD) population, but low 25OHD
      levels have been associated with poor muscle strength. In this protocol of an ongoing study
      named VITADIAL testing if cholecalciferol supplementation in hemodialysis patients with low
      25OHD improve their muscle strength.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective open randomized French multicenter study. All patients will have 25OHD levels
      ≤50nmol/L at randomization. One group will receive 100 000 UI cholecalciferol once a month
      during 6 months, the other group will receive no treatment during 6 months.

      In order to randomize patients with 25OHD ≤50nmol/L, supplemented patients will undergo a 3
      months wash-out period renewable 3 times (maximum of 12 months wash-out) until 25OHD reaches
      a level≤50nmol/L.

      The main objective of this study is to analyze if a 6 months period of oral cholecalciferol
      (i.e. native vitamin D) supplementation improves muscle strength of hemodialysis patients
      with low 25OHD vitamin D levels. Muscle strength will be assessed at 0, 3 and 6 months, by
      handgrip strength measured with a quantitative dynamometer.

      Secondary objectives are 1) to analyze 25OHD plasma levels after vitamin D wash-out and/or
      supplementation, as well as factors associated with 25OHD lowering speed during wash-out and
      2) to analyze if this supplementation improves patient's autonomy, reduces frailty risk and
      improves quality of life.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 8, 2018</start_date>
  <completion_date type="Anticipated">January 8, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 8, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Muscle strength evaluation after 6 months period after cholecalciferol or no vitamin D treatment</measure>
    <time_frame>At 6 months after randomization</time_frame>
    <description>Muscle strength will be assessed by handgrip strength measured with a quantitative dynamometer</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient's autonomy after 6 months period of oral cholecalciferol</measure>
    <time_frame>At 6 months post randomization (for patients treated)</time_frame>
    <description>Katz Index of Independence in Activities of Daily Living (ADL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient's frailty risk after 6 months period of oral cholecalciferol</measure>
    <time_frame>At 6 months post randomization (for patients treated)</time_frame>
    <description>The Frail Non-Disabled (FiND) Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient's quality of life after 6 months period of oral cholecalciferol</measure>
    <time_frame>At 6 months post randomization (for patients treated)</time_frame>
    <description>Kidney Disease Quality of Life (KDQOL-SFtm) Questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>hemoDIALysis Patients</condition>
  <arm_group>
    <arm_group_label>Cholecalciferol treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arm A : Cholecalciferol 100.000 UI - oral - every month</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Arm B : No vitamin D administration</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cholecalciferol 100.000 UI administration</intervention_name>
    <description>One oral Administration - Every month</description>
    <arm_group_label>Cholecalciferol treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No vitamin D administration</intervention_name>
    <description>No vitamin D administration</description>
    <arm_group_label>No treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        -  Inclusion Criteria:

               -  under hemodialysis for more than 3 months

               -  aged over 18 years-old

               -  gave their consent

          -  Non-inclusion criteria :

               -  non fluent French speaker

               -  incapacity to provide consent or to answer questionnaires

               -  pregnancy or breast feeding

               -  cognitive impairment

               -  bedridden or life expectancy &lt;1 year

               -  active cancer

               -  uncontrolled hyperparathyroidism as defined by the K-DIGO (iPTH&gt;9x normal
                  laboratory maximal value), cinacalcet treatment or hypocalcemia &lt;2.0 mmol/L or
                  hypercalcemia &gt;2.7mmol/L

               -  past osteoporosis fracture

               -  treatment with active vitamin D

               -  unable to perform handgrip measurement

               -  25OHD&gt;50nmol/L without vitamin D treatment

               -  cholecalciferol intolerance or allergy

          -  Exclusion Criteria:

               -  25OHD&gt;50nmol/L after 12 months wash-out

               -  hypercalcemia &gt;2.7mmol/L

               -  hyperparathyroidism (iPTH&gt;9x normal laboratory maximal value) during wash-out or
                  after randomization if patient is in the no treatment group

               -  hypoparathyroidism (iPTH&lt;3x normal laboratory lower value) in a patient receiving
                  cholecalciferol

               -  cholecalciferol intolerance or allergy

               -  death, renal transplantation

               -  pregnancy

               -  consent withdrawal

               -  renal recuperation allowing hemodialysis to stop

               -  unability to perform handgrip
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stanislas BATAILLE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut Phoceen de Nephrologie</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sandra COURNIER</last_name>
    <phone>+33 (0)4 91 15 94 10</phone>
    <email>recherche.clinique.ipn@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>COURNIER</name>
      <address>
        <city>Marseille</city>
        <zip>13006</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Stanislas BATAILLE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>https://www.nephrologuemarseille.fr</url>
    <description>Institut Phocéen de Néphrologie</description>
  </link>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>January 27, 2020</study_first_submitted>
  <study_first_submitted_qc>February 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 10, 2020</study_first_posted>
  <last_update_submitted>February 7, 2020</last_update_submitted>
  <last_update_submitted_qc>February 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>25 OH-VITAmin D supplementation</keyword>
  <keyword>muscle strength</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

